Positive predictive value of computerized records for major congenital malformations

Pharmacoepidemiology and Drug Safety

Volumn 17, Issue 5, 2008, Pages 455-460

  Cooper, William O ^a   Hernandez Diaz, Sonia ^b   Gideon, Patricia ^a   Dyer, Shannon M ^a   Hall, Kathleen ^a   Dudley, Judith ^a   Cevasco, Marisa ^a   Thompson, Amanda B ^a   Ray, Wayne A ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Congenital malformations; Positive predictive value; Vital records

Indexed keywords

ARTICLE; CALCULATION; CENTRAL NERVOUS SYSTEM MALFORMATION; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; DATA BASE; ELECTRONIC MEDICAL RECORD; FACE MALFORMATION; FEMALE; GASTROINTESTINAL DISEASE; HOSPITAL PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MEDICAID; MOTHER; MOUTH MALFORMATION; MUSCULOSKELETAL DISEASE; PREDICTION; PRIORITY JOURNAL; UROGENITAL TRACT MALFORMATION;

BIRTH CERTIFICATES; CONGENITAL ABNORMALITIES; DATABASES, FACTUAL; FEMALE; HUMANS; INFANT, NEWBORN; INSURANCE CLAIM REPORTING; MEDICAID; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; PREDICTIVE VALUE OF TESTS; TENNESSEE; UNITED STATES;

EID: 44249095342     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.1534     Document Type: Article

References (13)

1. Ray WA, Griffin MR. Use of Medicaid data for pharmacoepidemiology. Am J Epidemiol 1989; 129: 837-849.
2. Piper JM, Ray WA, Rosa FW. Pregnancy outcome following exposure to angiotensin-converting enzyme inhibitors. Obstet Gynecol 1992; 80: 429-432.
3. Cooper WO, Hernandez-Diaz S, Arbogast PG, et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. N Engl J Med 2006; 354: 2443-2451.
4. Piper JM, Ray WA, Griffin MR, Fought R, Daughtery JR, Mitchel E, Jr. Methodological issues in evaluating expanded Medicaid coverage for pregnant women. Am J Epidemiol 1990; 132: 561-571.
5. Dominitz JA, Young JC, Boyko EJ. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study. Am J Gastroenterol 2002; 97: 641-648.
6. Ofori B, Oraichi D, Blais L, Rey E, Berard A. Risk of congenital anomalies in pregnant users of non-steroidal anti-inflammatory drugs: a nested case-control study. Birth Defects Res B Dev Reprod Toxicol 2006; 77: 268-279.
7. Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 2007; 80: 18-27.
8. Piper JM, Mitchel EF, Jr, Snowden M, Hall C, Adams M, Taylor P. Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol 1993; 137: 758-768.
9. Feldkamp M, Macleod L, Young L, Lecheminant K, Carey JC. The methodology of the Utah Birth Defect Network: congenital heart defects as an illustration. Birth Defects Res A Clin Mol Teratol 2005; 73: 693-699.
10. Collins SR, Griffin MR, Arbogast PG, et al. The rising prevalence of gastroschisis and omphalocele in Tennessee. J Pediatr Surg 2007; 42: 1221-1224.
11. Centers For Disease Control And Prevention. Metropolitan Atlanta Congenital Defects Program Coding Manual. http://www.cdc.gov/ncbddd/bd/ macdp.htm, 8-11-2005, Ref Type: Electronic Citation.
12. Piper JM, Mitchel EF, Jr, Snowden M, Hall C, Adams M, Taylor P. Validation of 1989 Tennessee birth certificates using maternal and newborn hospital records. Am J Epidemiol 1993; 137: 758-768.
13. Watkins ML, Edmonds L, Mcclearn A, Mullins L, Mulinare J, Khoury M. The surveillance of birth defects: the usefulness of the revised US standard birth certificate. Am J Public Health 1996; 86: 731-734.